These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8969284)

  • 1. Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients.
    Linn T; Ortac K; Laube H; Federlin K
    Metabolism; 1996 Dec; 45(12):1508-13. PubMed ID: 8969284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course of insulin sensitivity and insulin reserve in early insulin-dependent diabetes mellitus.
    Linn T; Ebener K; Raptis G; Laube H; Federlin K
    Metabolism; 1995 May; 44(5):617-23. PubMed ID: 7752910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
    Schnell O; Eisfelder B; Standl E; Ziegler AG
    Diabetes; 1997 Oct; 46(10):1607-11. PubMed ID: 9313757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
    Kinsley BT; Levy CJ; Simonson DC
    Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus.
    Arslanian SA; Heil BV; Becker DJ; Drash AL
    J Clin Endocrinol Metab; 1991 Apr; 72(4):920-6. PubMed ID: 2005219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
    Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
    Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
    Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus.
    Montanya E; Fernandez-Castañer M; Soler J
    Diabetes Metab; 1997 Sep; 23(4):314-9. PubMed ID: 9342545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control.
    Kinsley BT; Widom B; Utzschneider K; Simonson DC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1383-9. PubMed ID: 7962332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.
    Vidal J; Fernández-Balsells M; Sesmilo G; Aguilera E; Casamitjana R; Gomis R; Conget I
    Diabetes Care; 2000 Mar; 23(3):360-4. PubMed ID: 10868866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
    Genuth S
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.